Scientists identify genes that disrupt response to breast cancer treatment

Editor’s notes: To reach Zeynep Madak-Erdogan, call 217-300-9063; email  zmadake2@illinois.edu

The study “Era-XPO1 crosstalk controls tamoxifen sensitivity in tumors by altering ERK5 cellular localization” is available online from the journal Molecular Endocrinology or from the News Bureau.

Original story posted here:
https://news.illinois.edu/blog/view/6367/404190